Pulmonary Drug Delivery Devices/Systems Market to 2027 – Global Analysis and Forecasts by Product (Capsule Endoscopy, Drug Delivery, Patient Monitoring) By Application (Asthma, COPD, Allergic Rhinitis, Cystic Fibrosis and Others) and By End User (Hospitals & Clinics, Research Institutes and Home Healthcare)
Report Code: TIPHE100001256 No. of Pages: 150 Category: Medical Device Status: Upcoming
Pulmonary drug delivery devices or systems includes devices for delivering drugs through medical devices such as inhalers and nebulizers in patients with respiratory illnesses such as asthma. The devices are based on diverse delivery mechanisms, and consist of types of drug formulations. Asthma, COPD, Allergic Rhinitis and Cystic Fibrosis are major respiratory diseases which require the use of drug delivery devices in case of emergency as well.
Pulmonary drug delivery devices/systems market exhibits potential growth during the forecast period. Factors contributing to the growth are technological advancements, rising prevalence of respiratory diseases and growing healthcare expenditure of therapeutic devices by developed countries across the globe. Additionally, uses of respiratory care devices as a part of home healthcare also fuels the market growth.
The “Global Pulmonary Drug Delivery Devices/Systems Market Analysis to 2027” is a specialized and in-depth study of the pulmonary drug delivery devices/systems industry with a focus on the global market trend. The report aims to provide an overview of global pulmonary drug delivery devices/systems market with detailed market segmentation by product, application, end user, and geography. The global pulmonary drug delivery devices/systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global pulmonary drug delivery devices/systems market is segmented on the basis of product, application, and end user. On the basis of product, the market is segmented into nebulizers, inhalers and accessories. Nebulizers is further segmented into mesh nebulizers, pneumatic nebulizers and ultrasonic nebulizers. Inhalers is further segmented into metered dose inhalers and dry powder inhalers.
On the basis of application, the market is segmented into asthma, COPD, allergic rhinitis, cystic fibrosis and others. On the basis of end user, the market is segmented into hospitals & clinics and home healthcare.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global pulmonary drug delivery devices/systems market based on product, application and end user. It also provides market size and forecast till 2027 for overall pulmonary drug delivery devices/systems market with respect to five major regions, namely; North America, Europe, APAC, Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
In North America, the market is mainly driven by increasing number of patients with COPD and asthma and rising demand for respiratory care devices. Moreover, urge of new product development and expansion of product portfolio by manufacturers in the US also drives the market. In Asia Pacific, India, China and Japan are the major contributors to the growth of the market. Rising environment pollution, high prevalence of respiratory disease and aging population are key driver of the market. In India, prevalence of COPD is high. Asthma is one of the major health concerns among the geriatric population.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key Pulmonary Drug Delivery Devices/Systems manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past five years. Some of the key players influencing the market are GlaxoSmithKline plc., Koninklijke Philips N.V., Boehringer Ingelheim International GmbH, 3M,AstraZeneca,Teva Pharmaceutical Industries Ltd. ,Aerogen Ltd.,Hovione, Hantel Technologies, H&T Presspart Manufacturing Ltd. and others.
Pulmonary drug delivery devices/systems market exhibits potential growth during the forecast period. Factors contributing to the growth are technological advancements, rising prevalence of respiratory diseases and growing healthcare expenditure of therapeutic devices by developed countries across the globe. Additionally, uses of respiratory care devices as a part of home healthcare also fuels the market growth.
The “Global Pulmonary Drug Delivery Devices/Systems Market Analysis to 2027” is a specialized and in-depth study of the pulmonary drug delivery devices/systems industry with a focus on the global market trend. The report aims to provide an overview of global pulmonary drug delivery devices/systems market with detailed market segmentation by product, application, end user, and geography. The global pulmonary drug delivery devices/systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global pulmonary drug delivery devices/systems market is segmented on the basis of product, application, and end user. On the basis of product, the market is segmented into nebulizers, inhalers and accessories. Nebulizers is further segmented into mesh nebulizers, pneumatic nebulizers and ultrasonic nebulizers. Inhalers is further segmented into metered dose inhalers and dry powder inhalers.
On the basis of application, the market is segmented into asthma, COPD, allergic rhinitis, cystic fibrosis and others. On the basis of end user, the market is segmented into hospitals & clinics and home healthcare.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global pulmonary drug delivery devices/systems market based on product, application and end user. It also provides market size and forecast till 2027 for overall pulmonary drug delivery devices/systems market with respect to five major regions, namely; North America, Europe, APAC, Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
In North America, the market is mainly driven by increasing number of patients with COPD and asthma and rising demand for respiratory care devices. Moreover, urge of new product development and expansion of product portfolio by manufacturers in the US also drives the market. In Asia Pacific, India, China and Japan are the major contributors to the growth of the market. Rising environment pollution, high prevalence of respiratory disease and aging population are key driver of the market. In India, prevalence of COPD is high. Asthma is one of the major health concerns among the geriatric population.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key Pulmonary Drug Delivery Devices/Systems manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past five years. Some of the key players influencing the market are GlaxoSmithKline plc., Koninklijke Philips N.V., Boehringer Ingelheim International GmbH, 3M,AstraZeneca,Teva Pharmaceutical Industries Ltd. ,Aerogen Ltd.,Hovione, Hantel Technologies, H&T Presspart Manufacturing Ltd. and others.
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Pulmonary Drug Delivery Devices/Systems Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Pulmonary Drug Delivery Devices/Systems Market – By Product
3.2.2 Pulmonary Drug Delivery Devices/Systems Market – By Application
3.2.3 Pulmonary Drug Delivery Devices/Systems Market – By End User
3.2.4 Pulmonary Drug Delivery Devices/Systems Market – By Region
3.2.4.1 By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America– PEST Analysis
4 Pulmonary Drug Delivery Devices/Systems Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Pulmonary Drug Delivery Devices/Systems Market – Global Analysis
5.1 Global Pulmonary Drug Delivery Devices/Systems Market Overview
5.2 Global Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
6 Pulmonary Drug Delivery Devices/Systems Market - Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South & Central America
7 Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – By Product
7.1 Overview
7.2 Product Market Forecasts and Analysis (US$ Mn)
7.3 Nebulizers Market
7.3.1 Overview
7.3.2 Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3 Mesh Nebulizers Market
7.3.3.1 Overview
7.3.3.2 Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3.3 Vibrating Mesh Nebulizes Market
7.3.3.3.1 Overview
7.3.3.3.2 Vibrating Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3.4 Static Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3.4.1 Overview
7.3.3.4.2 Static Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4 Pneumatic Nebulizers Market
7.3.4.1 Overview
7.3.4.2 Pneumatic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4.3 Vented Pneumatic Nebulizers Market
7.3.4.3.1 Overview
7.3.4.3.2 Vented Pneumatic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4.4 Breath Actuated Pneumatic Nebulizers Market
7.3.4.4.1 Overview
7.3.4.4.2 Breath Actuated Pneumatic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.5 Ultrasonic Nebulizers Market
7.3.5.1 Overview
7.3.5.2 Ultrasonic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Inhalers Market
7.4.1 Overview
7.4.2 Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3 Metered Dose Inhalers Market
7.4.3.1 Overview
7.4.3.2 Metered Dose Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4 Dry Powder Inhalers Market
7.4.4.1 Overview
7.4.4.2 Dry Powder Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Accessories Market
7.5.1 Overview
7.5.2 Accessories Market Revenue Forecasts and Analysis (US$ Mn)
8 Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – By Application
8.1 Overview
8.2 Application Market Forecasts and Analysis (US$ Mn)
8.3 Asthma Market
8.3.1 Overview
8.3.2 Asthma Market Revenue Forecasts and Analysis (US$ Mn)
8.4 COPD Market
8.4.1 Overview
8.4.2 COPD Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Allergic Rhinitis Market
8.5.1 Overview
8.5.2 Allergic Rhinitis Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Cystic Fibrosis Market
8.6.1 Overview
8.6.2 Cystic Fibrosis Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Applications Market
8.7.1 Overview
8.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
9 Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – By End User
9.1 Overview
9.2 End User Market Forecasts and Analysis
9.3 Hospitals & Clinics Market Forecasts and Analysis (US$ Mn)
9.3.1 Overview
9.3.2 Hospitals & Clinics Market Forecasts and Analysis (US$ Mn)
9.4 Home Healthcare Market
9.4.1 Overview
9.4.2 Home Healthcare Market Forecasts and Analysis (US$ Mn)
10 North America Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
10.1 North America Pulmonary Drug Delivery Devices/Systems Market Overview
10.2 North America Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
10.3.1 North America Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.3.2 North America Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.4 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
10.5 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
10.6 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country (US$ Mn)
10.7 US Market Overview
10.7.1 US Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.7.1.1 US Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.7.1.2 US Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.7.2 US Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
10.7.3 US Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.8 Canada Market Overview
10.8.1 Canada Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.1.1 Canada Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.8.1.2 Canada Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.8.2 Canada Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
10.8.3 Canada Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.9 Mexico Market Overview
10.9.1 Mexico Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.1.1 Mexico Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.9.1.2 Mexico Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.9.2 Mexico Market Forecasts and Analysis – By Application (US$ Mn)
10.9.3 Mexico Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11 Europe Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
11.1 Europe Pulmonary Drug Delivery Devices/Systems Market Overview
11.2 Europe Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
11.3.1 Europe Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.3.2 Europe Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.4 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.5 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
11.6 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country (US$ Mn)
11.7 UK Market Overview
11.7.1 UK Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.7.1.1 UK Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.7.1.2 UK Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.7.2 UK Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.7.3 UK Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.8 Germany Market Overview
11.8.1 Germany Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.1.1 Germany Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.8.1.2 Germany Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.8.2 Germany Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.8.3 Germany Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.9 France Market Overview
11.9.1 France Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.1.1 France Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.9.1.2 France Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.9.2 France Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.9.3 France Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
12.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Overview
12.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
12.3.1 Asia Pacific Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.3.2 Asia Pacific Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.4 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.5 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
12.6 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country
12.7 Japan Market Overview
12.7.1 Japan Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.7.1.1 Japan Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.7.1.2 Japan Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.7.2 Japan Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.7.3 Japan Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.8 China Market Overview
12.8.1 China Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.1.1 China Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.8.1.2 China Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.8.2 China Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.8.3 China Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.9 India Market Overview
12.9.1 India Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.1.1 India Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.9.1.2 India Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.9.2 India Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.9.3 India Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
13.1 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Overview
13.2 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
13.3.1 Middle East and Africa (MEA) Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.3.2 Middle East and Africa (MEA) Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.4 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.5 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
13.6 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country
13.7 South Africa Market Overview
13.7.1 South Africa Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.7.1.1 South Africa Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.7.1.2 South Africa Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.7.2 South Africa Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.7.3 South Africa Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.8 Saudi Arabia Market Overview
13.8.1 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.8.1.1 Saudi Arabia Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.8.1.2 Saudi Arabia Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.8.2 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.8.3 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.9 UAE Market Overview
13.9.1 UAE Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.9.1.1 UAE Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.9.1.2 UAE Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.9.2 UAE Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.9.3 UAE Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
14 South and Central America Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
14.1 South and Central America Pulmonary Drug Delivery Devices/Systems Market Overview
14.2 South and Central America Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
14.3.1 South and Central America Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
14.3.2 South and Central America Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
14.4 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
14.5 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
14.6 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country
14.7 Brazil Market Overview
14.7.1 Brazil Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
14.7.1.1 Brazil Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
14.7.1.2 Brazil Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
14.7.2 Brazil Smarty Pills Market Forecasts and Analysis – By Application (US$ Mn)
14.7.3 Brazil Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Product Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
16 Pulmonary Drug Delivery Devices/Systems Market, Key Company Profiles
16.1 GlaxoSmithKline plc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Koninklijke Philips N.V.
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Boehringer Ingelheim International GmbH
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 3M
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 AstraZeneca
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Teva Pharmaceutical Industries Ltd.
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Aerogen Ltd.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 Hovione
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 Hantel Technologies
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 H&T Presspart Manufacturing Ltd.
16.10.1Key Facts
16.10.2Business Description
16.10.3Financial Overview
16.10.4Product Portfolio
16.10.5Product Pipeline
16.10.6SWOT Analysis
16.10.7Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
2 Key Takeaways
3 Pulmonary Drug Delivery Devices/Systems Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Pulmonary Drug Delivery Devices/Systems Market – By Product
3.2.2 Pulmonary Drug Delivery Devices/Systems Market – By Application
3.2.3 Pulmonary Drug Delivery Devices/Systems Market – By End User
3.2.4 Pulmonary Drug Delivery Devices/Systems Market – By Region
3.2.4.1 By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America– PEST Analysis
4 Pulmonary Drug Delivery Devices/Systems Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis
5 Pulmonary Drug Delivery Devices/Systems Market – Global Analysis
5.1 Global Pulmonary Drug Delivery Devices/Systems Market Overview
5.2 Global Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
6 Pulmonary Drug Delivery Devices/Systems Market - Global Regulatory Scenario
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia Pacific
6.5 Middle East & Africa
6.6 South & Central America
7 Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – By Product
7.1 Overview
7.2 Product Market Forecasts and Analysis (US$ Mn)
7.3 Nebulizers Market
7.3.1 Overview
7.3.2 Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3 Mesh Nebulizers Market
7.3.3.1 Overview
7.3.3.2 Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3.3 Vibrating Mesh Nebulizes Market
7.3.3.3.1 Overview
7.3.3.3.2 Vibrating Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3.4 Static Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3.4.1 Overview
7.3.3.4.2 Static Mesh Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4 Pneumatic Nebulizers Market
7.3.4.1 Overview
7.3.4.2 Pneumatic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4.3 Vented Pneumatic Nebulizers Market
7.3.4.3.1 Overview
7.3.4.3.2 Vented Pneumatic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4.4 Breath Actuated Pneumatic Nebulizers Market
7.3.4.4.1 Overview
7.3.4.4.2 Breath Actuated Pneumatic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.5 Ultrasonic Nebulizers Market
7.3.5.1 Overview
7.3.5.2 Ultrasonic Nebulizers Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Inhalers Market
7.4.1 Overview
7.4.2 Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3 Metered Dose Inhalers Market
7.4.3.1 Overview
7.4.3.2 Metered Dose Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4 Dry Powder Inhalers Market
7.4.4.1 Overview
7.4.4.2 Dry Powder Inhalers Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Accessories Market
7.5.1 Overview
7.5.2 Accessories Market Revenue Forecasts and Analysis (US$ Mn)
8 Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – By Application
8.1 Overview
8.2 Application Market Forecasts and Analysis (US$ Mn)
8.3 Asthma Market
8.3.1 Overview
8.3.2 Asthma Market Revenue Forecasts and Analysis (US$ Mn)
8.4 COPD Market
8.4.1 Overview
8.4.2 COPD Market Revenue Forecasts and Analysis (US$ Mn)
8.5 Allergic Rhinitis Market
8.5.1 Overview
8.5.2 Allergic Rhinitis Market Revenue Forecasts and Analysis (US$ Mn)
8.6 Cystic Fibrosis Market
8.6.1 Overview
8.6.2 Cystic Fibrosis Market Revenue Forecasts and Analysis (US$ Mn)
8.7 Other Applications Market
8.7.1 Overview
8.7.2 Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
9 Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – By End User
9.1 Overview
9.2 End User Market Forecasts and Analysis
9.3 Hospitals & Clinics Market Forecasts and Analysis (US$ Mn)
9.3.1 Overview
9.3.2 Hospitals & Clinics Market Forecasts and Analysis (US$ Mn)
9.4 Home Healthcare Market
9.4.1 Overview
9.4.2 Home Healthcare Market Forecasts and Analysis (US$ Mn)
10 North America Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
10.1 North America Pulmonary Drug Delivery Devices/Systems Market Overview
10.2 North America Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
10.3 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
10.3.1 North America Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.3.2 North America Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.4 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
10.5 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
10.6 North America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country (US$ Mn)
10.7 US Market Overview
10.7.1 US Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.7.1.1 US Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.7.1.2 US Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.7.2 US Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
10.7.3 US Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.8 Canada Market Overview
10.8.1 Canada Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.1.1 Canada Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.8.1.2 Canada Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.8.2 Canada Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
10.8.3 Canada Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.9 Mexico Market Overview
10.9.1 Mexico Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.1.1 Mexico Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
10.9.1.2 Mexico Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
10.9.2 Mexico Market Forecasts and Analysis – By Application (US$ Mn)
10.9.3 Mexico Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11 Europe Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
11.1 Europe Pulmonary Drug Delivery Devices/Systems Market Overview
11.2 Europe Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
11.3.1 Europe Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.3.2 Europe Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.4 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.5 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
11.6 Europe Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country (US$ Mn)
11.7 UK Market Overview
11.7.1 UK Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.7.1.1 UK Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.7.1.2 UK Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.7.2 UK Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.7.3 UK Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.8 Germany Market Overview
11.8.1 Germany Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.1.1 Germany Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.8.1.2 Germany Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.8.2 Germany Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.8.3 Germany Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.9 France Market Overview
11.9.1 France Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.1.1 France Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
11.9.1.2 France Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
11.9.2 France Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
11.9.3 France Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
12.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Overview
12.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
12.3.1 Asia Pacific Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.3.2 Asia Pacific Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.4 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.5 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
12.6 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country
12.7 Japan Market Overview
12.7.1 Japan Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.7.1.1 Japan Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.7.1.2 Japan Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.7.2 Japan Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.7.3 Japan Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.8 China Market Overview
12.8.1 China Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.1.1 China Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.8.1.2 China Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.8.2 China Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.8.3 China Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.9 India Market Overview
12.9.1 India Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.1.1 India Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
12.9.1.2 India Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
12.9.2 India Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
12.9.3 India Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
13.1 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Overview
13.2 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
13.3 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
13.3.1 Middle East and Africa (MEA) Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.3.2 Middle East and Africa (MEA) Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.4 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.5 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
13.6 Middle East and Africa (MEA) Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country
13.7 South Africa Market Overview
13.7.1 South Africa Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.7.1.1 South Africa Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.7.1.2 South Africa Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.7.2 South Africa Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.7.3 South Africa Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.8 Saudi Arabia Market Overview
13.8.1 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.8.1.1 Saudi Arabia Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.8.1.2 Saudi Arabia Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.8.2 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.8.3 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.9 UAE Market Overview
13.9.1 UAE Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.9.1.1 UAE Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
13.9.1.2 UAE Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
13.9.2 UAE Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
13.9.3 UAE Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
14 South and Central America Pulmonary Drug Delivery Devices/Systems Market Revenue and Forecasts to 2027 – Country Analysis
14.1 South and Central America Pulmonary Drug Delivery Devices/Systems Market Overview
14.2 South and Central America Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis (US$ Mn)
14.3 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Product (US$ Mn)
14.3.1 South and Central America Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
14.3.2 South and Central America Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
14.4 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Application (US$ Mn)
14.5 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By End User (US$ Mn)
14.6 South and Central America Pulmonary Drug Delivery Devices/Systems Market Forecasts and Analysis – By Country
14.7 Brazil Market Overview
14.7.1 Brazil Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By Product (US$ Mn)
14.7.1.1 Brazil Nebulizers Market Forecasts and Analysis – By Type (US$ Mn)
14.7.1.2 Brazil Inhalers Market Forecasts and Analysis – By Type (US$ Mn)
14.7.2 Brazil Smarty Pills Market Forecasts and Analysis – By Application (US$ Mn)
14.7.3 Brazil Pulmonary Drug Delivery Devices/Systems Market Revenue Forecasts and Analysis-By End User (US$ Mn)
15 Industry Landscape
15.1 Organic Growth Strategies
15.1.1 New Product Launches
15.1.2 Marketing & Promotional Activities
15.2 Inorganic Growth Strategies
15.2.1 Partnerships, Collaborations, and Joint Ventures
15.2.2 Mergers & Acquisitions
16 Pulmonary Drug Delivery Devices/Systems Market, Key Company Profiles
16.1 GlaxoSmithKline plc.
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Financial Overview
16.1.4 Product Portfolio
16.1.5 Product Pipeline
16.1.6 SWOT Analysis
16.1.7 Key Developments
16.2 Koninklijke Philips N.V.
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Financial Overview
16.2.4 Product Portfolio
16.2.5 Product Pipeline
16.2.6 SWOT Analysis
16.2.7 Key Developments
16.3 Boehringer Ingelheim International GmbH
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Financial Overview
16.3.4 Product Portfolio
16.3.5 Product Pipeline
16.3.6 SWOT Analysis
16.3.7 Key Developments
16.4 3M
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Financial Overview
16.4.4 Product Portfolio
16.4.5 Product Pipeline
16.4.6 SWOT Analysis
16.4.7 Key Developments
16.5 AstraZeneca
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Financial Overview
16.5.4 Product Portfolio
16.5.5 Product Pipeline
16.5.6 SWOT Analysis
16.5.7 Key Developments
16.6 Teva Pharmaceutical Industries Ltd.
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Financial Overview
16.6.4 Product Portfolio
16.6.5 Product Pipeline
16.6.6 SWOT Analysis
16.6.7 Key Developments
16.7 Aerogen Ltd.
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Financial Overview
16.7.4 Product Portfolio
16.7.5 Product Pipeline
16.7.6 SWOT Analysis
16.7.7 Key Developments
16.8 Hovione
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Financial Overview
16.8.4 Product Portfolio
16.8.5 Product Pipeline
16.8.6 SWOT Analysis
16.8.7 Key Developments
16.9 Hantel Technologies
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Financial Overview
16.9.4 Product Portfolio
16.9.5 Product Pipeline
16.9.6 SWOT Analysis
16.9.7 Key Developments
16.10 H&T Presspart Manufacturing Ltd.
16.10.1Key Facts
16.10.2Business Description
16.10.3Financial Overview
16.10.4Product Portfolio
16.10.5Product Pipeline
16.10.6SWOT Analysis
16.10.7Key Developments
17 Appendix
17.1 About The Insight Partners
17.2 Glossary of Terms
17.3 Research Methodology
The List of Companies
1. GlaxoSmithKline plc.
2. Koninklijke Philips N.V.
3. Boehringer Ingelheim International GmbH
4. 3M
5. AstraZeneca
6. Teva Pharmaceutical Industries Ltd.
7. Aerogen Ltd.
8. Hovione
9. Hantel Technologies
10. H&T Presspart Manufacturing Ltd.
1. GlaxoSmithKline plc.
2. Koninklijke Philips N.V.
3. Boehringer Ingelheim International GmbH
4. 3M
5. AstraZeneca
6. Teva Pharmaceutical Industries Ltd.
7. Aerogen Ltd.
8. Hovione
9. Hantel Technologies
10. H&T Presspart Manufacturing Ltd.